Senestech (SNES) Registration Filing summary

Company overview and business model

• Develops and commercializes fertility control products for managing rat and mouse populations, including ContraPest, Evolve Rat, and Evolve Mouse.

• Products target reproductive systems of rodents, offering a humane alternative to traditional rodenticides and aligning with growing environmental concerns.

• ContraPest is a liquid bait registered in all 50 states and major U.S. territories; Evolve products are classified as minimum risk pesticides and are authorized in most states.

• Focuses on continuous product enhancement and regulatory expansion, with plans to seek approvals outside the U.S. when feasible.

Financial performance and metrics

• Has incurred operating losses since inception and expects to continue incurring significant expenses and losses for the foreseeable future.

• Financial statements as of December 31, 2024, include a going concern warning due to net loss from operations and net capital deficiency.

Use of proceeds and capital allocation

• Will not receive proceeds from resale of shares by selling stockholders, except for cash received from warrant exercises.

• Proceeds from warrant exercises will be used for general corporate purposes, including R&D, capital expenditures, working capital, administrative expenses, and potential acquisitions or investments, though no such commitments exist as of the filing date.